The Oncology Institute Achieves $1.1 Million in Medicare Savings in CMS Enhancing Oncology Model Performance Period 2 through its California Professional Corporation
The Oncology Institute (NASDAQ: TOI) has reported significant Medicare savings of $1.1 million during Performance Period 2 of the CMS Enhancing Oncology Model (EOM) through its California professional corporation. The company achieved savings of over $3,500 per patient episode and earned maximum scores for reducing avoidable emergency department visits and hospital admissions.
The success was attributed to TOI's High Value Cancer Care program, featuring Health Care Coaches and 24/7 symptom management support. This performance builds on TOI's previous achievements in CMS's Oncology Care Model, where it exceeded quality standards and generated multi-million-dollar Medicare savings.
L'Oncology Institute (NASDAQ: TOI) ha riportato significativi risparmi Medicare di 1,1 milioni di dollari durante il Periodo di Prestazione 2 del CMS Enhancing Oncology Model tramite la sua società professionale in California. L'azienda ha ottenuto risparmi superiori a 3.500 dollari per episodio paziente e ha meritato punteggi massimi per la riduzione delle visite al pronto soccorso evitabili e delle ammissioni ospedaliere.
Il successo è attribuito al programma High Value Cancer Care di TOI, che comprende Health Care Coaches e supporto per la gestione dei sintomi 24/7. Questo risultato si basa sui precedenti traguardi di TOI nel CMS Oncology Care Model, dove ha superato gli standard di qualità e generato risparmi Medicare multimilionari.
El Oncology Institute (NASDAQ: TOI) ha informado importantes ahorros de Medicare de 1,1 millones de dólares durante el Periodo de Desempeño 2 del CMS Enhancing Oncology Model, a través de su corporación profesional en California. La empresa logró ahorros de más de 3.500 dólares por episodio de paciente y obtuvo puntuaciones máximas por reducir las visitas evitables a emergencias y las admisiones hospitalarias.
El éxito se atribuye al programa High Value Cancer Care de TOI, que cuenta con Health Care Coaches y soporte de gestión de síntomas 24/7. Este rendimiento se apoya en los logros previos de TOI en el Oncology Care Model de CMS, donde superó los estándares de calidad y generó ahorros de Medicare de varios millones de dólares.
온콜로지 연구소(주식코드: TOI)는 CALIFORNIA에 있는 전문 회사를 통해 CMS Enhancing Oncology Model의 성과 기간 2 동안 Medicare 절감액으로 110만 달러를 보고했습니다. 환자 1회 에피소드당 3,500달러 이상의 절감을 달성했고, 피할 수 있는 응급실 방문 및 입원을 줄이는 데 대해 최고 점수를 받았습니다.
이 성공은 TOI의 High Value Cancer Care 프로그램 덕분으로, Health Care Coaches와 24/7 증상 관리 지원을 제공합니다. 이 성과는 CMS의 Oncology Care Model에서 TOI가 품질 기준을 초과하고 Medicare 절감을 수백만 달러로 창출한 이전 성과에 기반합니다.
L'Oncology Institute (NASDAQ: TOI) a annoncé des économies Medicare importantes de 1,1 million de dollars pendant la Période de Performance 2 du CMS Enhancing Oncology Model, via sa société professionnelle californienne. L'entreprise a réalisé des économies de plus de 3 500 dollars par épisode patient et a obtenu les scores maximaux pour la réduction des visites évitables aux urgences et les admissions hospitalières.
Ce succès est attribué au programme High Value Cancer Care de TOI, qui comprend des Health Care Coaches et un soutien à la gestion des symptômes 24/7. Cette performance s'appuie sur les réalisations précédentes de TOI dans le CMS Oncology Care Model, où elle a dépassé les normes de qualité et généré des économies Medicare de plusieurs millions de dollars.
Das Oncology Institute (NASDAQ: TOI) hat während der Leistungsperiode 2 des CMS Enhancing Oncology Model über seine kalifornische Berufsausübungsfirma signifikante Medicare-Einsparungen von 1,1 Mio. USD gemeldet. Die Einsparungen betrugen über 3.500 USD pro Patientenpisode, und es wurden Höchstwerte für die Reduzierung vermeidbarer Notaufnahmebesuche und Krankenhausaufnahmen erreicht.
Der Erfolg wird dem High Value Cancer Care-Programm von TOI zugeschrieben, das Health Care Coaches und 24/7-Symptommanagement-Unterstützung bietet. Diese Leistung baut auf TOIs frühere Erfolge im CMS Oncology Care Model auf, bei dem es die Qualitätsstandards übertraf und Medicare-Einsparungen in mehreren Millionenbeträgen erzielte.
أبلغ معهد الأورراكونولوجي (المدرج في ناسداك: TOI) عن توفيرات كبيرة في Medicare بلغت 1.1 مليون دولار خلال فترة الأداء 2 من نموذج CMS Enhancing Oncology Model من خلال شركته المهنية في كاليفورنيا. حققت الشركة توفيرات تفوق 3,500 دولار لكل حلقة مريضة وحصلت على أعلى الدرجات في تقليل زيارات الطوارئ القابلة لتفاديها وعمليات الدخول إلى المستشفى.
ويُعزى النجاح إلى برنامج TOI للعناية بالسرطان عالي القيمة، المزوَّد بمدربي الرعاية الصحية ودعم إدارة الأعراض على مدار 24/7. يعزز هذا الأداء الإنجازات السابقة لـ TOI في نموذج رعاية الأورام CMS، حيث فاقت معايير الجودة وحققت مدخرات Medicare بمبالغ عدة ملايين.
肿瘤研究所（纳斯达克代码：TOI）通过其在加州的专业公司，在 CMS Enhancing Oncology Model 的绩效期2中报告了 110万美元的 Medicare 节省。公司实现了每位患者 epis ode 超过 3,500 美元的节省，并因减少可避免的急诊就诊和住院而获得最高评分。
这一成就归功于 TOI 的 High Value Cancer Care 计划，该计划提供健康护理教练和全时段（24/7）症状管理支持。此次表现是在 TOI 过去在 CMS Oncology Care Model 中超越质量标准并创造多百万美元 Medicare 节省的基础上取得的。
- Achieved $1.1 million in Medicare savings through EOM program
- Earned maximum score on avoidable emergency department visits and hospital admissions
- Generated savings of over $3,500 per patient episode
- Successfully implemented 24/7 symptom management support system
- None.
Insights
TOI's value-based model delivers $1.1M Medicare savings with superior quality metrics, validating their care approach as financially sustainable.
The Oncology Institute's $1.1 million in Medicare savings during the second performance period of CMS's Enhancing Oncology Model (EOM) represents meaningful financial validation of their value-based care approach. The savings of $3,500 per patient episode demonstrates significant cost efficiency in cancer treatment delivery while maintaining high clinical standards. This is particularly impressive considering the complexity and typically high cost of oncology care.
Achieving maximum quality scores on key metrics like avoidable emergency department visits and hospital admissions indicates TOI's care model is successfully managing patient symptoms and complications that typically drive excessive healthcare spending. Their proactive approach through Health Care Coaches and 24/7 symptom management directly addresses two major cost drivers in oncology: emergency care and hospitalizations.
This performance builds on TOI's previous success in CMS's Oncology Care Model, suggesting consistent execution of their value-based strategy across multiple payment models. For a public company focused on value-based oncology care, these results serve as quantifiable evidence that their model can simultaneously improve clinical outcomes while reducing costs – the essential formula for success under value-based payment models that are increasingly common in healthcare.
The financial implications extend beyond the direct savings, as successful participation in these programs positions TOI favorably for future value-based contracts with both government and commercial payers, potentially expanding their competitive advantage in markets transitioning away from fee-for-service payment models.
Practice earns maximum quality points on avoidable ED visits and admissions, saving more than
CERRITOS, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute of Hope and Innovation (NASDAQ: TOI), a leading value-based oncology practice, achieved
EOM is a voluntary total-cost-of-care model created by the CMS Innovation Center to advance high-quality, person-centered, and equitable cancer care for Medicare Fee-for-Service beneficiaries.
“These results again prove that our proactive navigation and real-time symptom management reduce unnecessary hospital visits and keep patients on treatment,” said Dr. Yale D. Podnos, Chief Medical Officer and President of Practice. “Patients across all our markets have access to these proven best practices to ensure each patient receives the right care at the right time.”
“This performance reinforces TOI’s leadership in value-based oncology,” said Dan Virnich, Chief Executive Officer. “By delivering measurable savings while improving quality, we continue to demonstrate that high-value cancer care is both clinically superior and financially sustainable.”
TOI’s success in EOM builds on its track record in CMS’s prior Oncology Care Model, where the organization exceeded quality standards and generated multi-million-dollar savings for Medicare.
About The Oncology Institute (www.theoncologyinstitute.com):
Founded in 2007, The Oncology Institute (NASDAQ: TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of approximately 1.9 million patients, including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With over 180 employed and affiliate clinicians and over 100 clinics and affiliate locations of care across five states and growing, TOI is changing oncology for the better.
Media
The Oncology Institute, Inc.
marketing@theoncologyinstitute.com
Investors
ICR Healthcare
TOI@icrhealthcare.com
FAQ
How much did The Oncology Institute (TOI) save in Medicare costs during EOM Performance Period 2?
What was the per-episode savings achieved by TOI in the EOM program?
How did TOI achieve its Medicare savings in the EOM program?
What quality metrics did TOI achieve in the CMS Enhancing Oncology Model?
What is TOI's track record in CMS oncology care programs?
